GB2398495B - A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug - Google Patents

A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug

Info

Publication number
GB2398495B
GB2398495B GB0301562A GB0301562A GB2398495B GB 2398495 B GB2398495 B GB 2398495B GB 0301562 A GB0301562 A GB 0301562A GB 0301562 A GB0301562 A GB 0301562A GB 2398495 B GB2398495 B GB 2398495B
Authority
GB
United Kingdom
Prior art keywords
drug
tumour
topical carrier
delivery preparation
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB0301562A
Other versions
GB2398495A (en
GB0301562D0 (en
Inventor
Kent G Lau
Sunil Chopra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0301562A priority Critical patent/GB2398495B/en
Publication of GB0301562D0 publication Critical patent/GB0301562D0/en
Publication of GB2398495A publication Critical patent/GB2398495A/en
Application granted granted Critical
Publication of GB2398495B publication Critical patent/GB2398495B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0301562A 2003-01-23 2003-01-23 A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug Expired - Lifetime GB2398495B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0301562A GB2398495B (en) 2003-01-23 2003-01-23 A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0301562A GB2398495B (en) 2003-01-23 2003-01-23 A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug

Publications (3)

Publication Number Publication Date
GB0301562D0 GB0301562D0 (en) 2003-02-26
GB2398495A GB2398495A (en) 2004-08-25
GB2398495B true GB2398495B (en) 2007-08-22

Family

ID=9951672

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0301562A Expired - Lifetime GB2398495B (en) 2003-01-23 2003-01-23 A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug

Country Status (1)

Country Link
GB (1) GB2398495B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015120720A (en) * 2005-02-02 2015-07-02 ネクスジェニクス・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー Local treatment of neurofibromas

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1854465A1 (en) 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
GB0623768D0 (en) * 2006-11-28 2007-01-10 Chopra Sunil A bleomycin preparation for use against skin tumours
GB2595502B (en) * 2020-05-28 2023-01-11 Chopra Sunil Compounds, compositions and methods for the treatment or prevention of hair loss

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156719A (en) * 1977-02-28 1979-05-29 Yamanouchi Pharmaceutical Co., Ltd. Compositions for rectal use
EP0219922A2 (en) * 1985-10-15 1987-04-29 Vestar, Inc. Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
JPH0374334A (en) * 1989-08-11 1991-03-28 Nippon Oil & Fats Co Ltd Reinforcing of carcinostatic property of bleomycin
EP0526666A1 (en) * 1991-08-05 1993-02-10 Maria Rosa Gasco Solid lipid microspheres having a narrow size distribution and method for producing them
GB2315216A (en) * 1993-10-05 1998-01-28 Ciba Geigy Ag Microemulsion preconcentrates comprising FK 506
GB2327610A (en) * 1994-11-04 1999-02-03 Novartis Ag Stabilisation of Macrolide Compositions
WO2000024377A1 (en) * 1998-10-23 2000-05-04 Idea Innovative Dermale Applikationen Gmbh Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156719A (en) * 1977-02-28 1979-05-29 Yamanouchi Pharmaceutical Co., Ltd. Compositions for rectal use
EP0219922A2 (en) * 1985-10-15 1987-04-29 Vestar, Inc. Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
JPH0374334A (en) * 1989-08-11 1991-03-28 Nippon Oil & Fats Co Ltd Reinforcing of carcinostatic property of bleomycin
EP0526666A1 (en) * 1991-08-05 1993-02-10 Maria Rosa Gasco Solid lipid microspheres having a narrow size distribution and method for producing them
GB2315216A (en) * 1993-10-05 1998-01-28 Ciba Geigy Ag Microemulsion preconcentrates comprising FK 506
GB2327610A (en) * 1994-11-04 1999-02-03 Novartis Ag Stabilisation of Macrolide Compositions
WO2000024377A1 (en) * 1998-10-23 2000-05-04 Idea Innovative Dermale Applikationen Gmbh Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WPI Acc. No. 1991-136900 [25] & JP 3074334 A (NIPPON OILS & FATS) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015120720A (en) * 2005-02-02 2015-07-02 ネクスジェニクス・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー Local treatment of neurofibromas

Also Published As

Publication number Publication date
GB2398495A (en) 2004-08-25
GB0301562D0 (en) 2003-02-26

Similar Documents

Publication Publication Date Title
IL165480A0 (en) Topical drug delivery using phosphatidylcholine
IL174690A0 (en) Enhanced drug delivery
GB2421914B (en) Delivery devices
GB2405350B (en) Delivery devices
EP1379291A4 (en) Integrated medication delivery system
GB2421689B (en) Drug delivery system
SI1631255T1 (en) Drug delivery system
GB0400024D0 (en) Delivery devices
EP1450876A4 (en) Integrated transdermal drug delivery system
GB2385273B (en) Drug delivery device
HK1080015A1 (en) Drug delivery assembly
ZA200510411B (en) Delivery system for topical medications
GB2398495B (en) A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug
GB0215593D0 (en) New anticancer drugs
IL156837A0 (en) Topical drug delivery system
GB0217478D0 (en) Multiple-therapy drug delivery
GB0209411D0 (en) Drug delivery
GB0311084D0 (en) Drug delivery
GB0329141D0 (en) Drug delivery
GB0118366D0 (en) Multiple-therapy drug delivery
GB0102667D0 (en) Drug delivery
IL151579A0 (en) Drug delivery device
PT1393763T (en) Drug delivery device
GB0313748D0 (en) Drug delivery compounds
GB0102586D0 (en) Drug delivery device

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20230122